|
 |
| home > pmps > winter 2002 > improving the clinical trial supply chain by using best practice techniques |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
What's the best way to ensure that clinical trial compounds are correctly packaged, labelled and delivered, while still maintaining tight control of costs? That's an increasingly critical question for companies in the pharmaceutical industry, where better manufacturing and supply processes can make the difference between a smooth and timely clinical trial and a costly debacle - drug makers lose up to a million US dollars in sales for each day a new drug's market launch is delayed.
As clinical studies become more complex and protracted, these supply chain issues grow even more pressing. To meet the challenge, leading pharmaceutical companies are implementing best practice processes, such as the deployment of cross-functional project teams. But many companies are still not using software tools to optimise production planning and execution.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Harald Geimer, Director of Worldwide Life Sciences and
Frank H Schulze, Principal of Worldwide Life Sciences Practice at PRTM
Harald Geimer is Director of Worldwide Life Sciences Practice at PRTM. He has over 14 years' consulting experience, primarily in supply chain management and product and process development, spanning the pharmaceutical, biotech, chemicals and medical devices industries.
Harald has led projects for companies to facilitate improvement in product development, supply chain management processes and outsourcing strategies. His consulting experience prior to joining PRTM, focused on business process re-engineering in the area of logistics, and marketing and service development in purchasing and supply management.
Harald holds a Masters Degree in Business Studies and Engineering from the Technical University in Darmstadt, Germany.
Frank H Schulze is Principal of Worldwide Life Sciences Practice at PRTM. He has 15 years of industry and consulting experience in developing business strategies and organisational concepts, sales and marketing, strategic product portfolio analysis, optimising R&D portfolios, integrating acquisitions and managing projects within the pharmaceutical, chemical, consumer and medical diagnostics industries. Prior to joining PRTM, Frank worked as General Manager of the Central and Eastern European Region for Hoechst Marion Roussel (now Aventis).
He was a Team Leader for the merger of Hoechst and Roussel in Europe and Latin America and managed the integration of Marion Merrill Dow (MMD). Frank also held senior management positions in several pharmaceutical and chemical companies. He has a PhD in Science from the Max-Planck-Institut in Gцttingen, Germany and a Masters Degree in Biology from the University of Heidelberg.
|
|
|
|
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
New PFA SonicLineŽ ultrasonic flowmeters
Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLineŽ ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLineŽ is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >> |
|
 |
